ProSavin: A gene therapy for Parkinson's Disease

被引：0

作者：

Jarraya, Bechir ^{[1
]}

Ralph, Scott ^{[2
]}

Lepetit, Helene ^{[1
]}

Boulet, Sabrina ^{[3
]}

Jan, Caroline ^{[3
]}

Bonvento, Gilles ^{[3
]}

Azzouz, Mimoun ^{[4
]}

Miskin, James ^{[2
]}

Gurruchaga, Jean Marc ^{[1
]}

Palfi, Stephane ^{[1
]}

Fenelon, Gilles ^{[1
]}

Brugiere, Pierre ^{[1
]}

Day, Debbie ^{[2
]}

Kingsman, Susan ^{[2
]}

Hantraye, Philippe ^{[3
]}

Remy, Philippe ^{[1
]}

Mitrophanous, Kyriacos ^{[2
]}

Mazarakis, Nickolas ^{[5
]}

Palfi, Stephane ^{[1
]}

机构：

[1] Univ Paris 12, Hop Henri Mondor, F-94010 Creteil, France

[2] Oxford Biomed, Biol, Oxford, England

[3] CEA, Fontenay Aux Roses, France

[4] Univ Sheffield, Sheffield, S Yorkshire, England

[5] Univ London Imperial Coll Sci Technol & Med, London, England

来源：

HUMAN GENE THERAPY | 2008年 / 19卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：1060 / 1061

页数：2

共 50 条

[1] ProSavin a gene therapy approach for Parkinson's disease
Jarraya, Bechir
Lepitit, Helene
Ralph, Scott
Tani, Naoki
Boulet, Sabrina
Jan, Caroline
Bonvento, Gilles
Miskin, James
Gurruchaga, Jean-Marc
Vinti, Maria
Fenelon, Gilles
Brugiere, Pierre
Kingsman, Susan
Hantraye, Philippe
Remy, Philippe
Mitrophanous, Kyriacos
Palfi, Stephane
HUMAN GENE THERAPY, 2009, 20 (11) : 1391 - 1392
[2] ProSavin® a Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial Update
Palfi, Stephane
Watts, Colin
Gurrachaga, Jean-Marc
Buttery, Philip
Ralph, Scott
Deeley, Saray
Lepetit, Helene
Miskin, James
Iwamuro, Hirokazu
Lavisse, Sonia
Kas, Aurelie
Ramelli, Anne Laure
Tani, Naoki
Dolphin, Patrice
Abhay, K.
Gabriel, I.
Fenelon, Gilles
Brugiere, Pierre
Naylor, Stuart
Hantraye, Philippe
Remy, Philippe
Barker, Roger
Mitrophanous, Kyriacos
MOLECULAR THERAPY, 2012, 20 : S23 - S23
[3] ProSavin® a Dopamine Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial
Palfi, S.
Gurruchaga, J. -M.
Ralph, G. S.
Watts, C.
Buttery, P.
Scorer, S.
Lepetit, H.
Miskin, J.
Iwamuro, H.
Lavisse, S.
Kas, A.
Ramelli, A. L.
Tani, N.
Dolphin, P.
Fenelon, G.
Brugiere, P.
Kingsman, S.
Naylor, S.
Hantraye, P.
Remy, P.
Barker, R.
Mitrophanous, K.
CELL TRANSPLANTATION, 2013, 22 (05) : 911 - 911
[4] Nonclinical and clinical development of ProSavin, an EIAV-based gene therapy for Parkinson's disease
Jarraya, B.
Ralph, G. S.
Shin, M.
Bonvento, G.
Jan, C.
Delzecaux, T.
Drouot, X.
Herard, A. -S.
Brouillet, E.
Conde, F.
Day, D.
Stratful, E.
Miskin, J.
McDonald, M.
Kingsman, S. M.
Hantraye, P.
Mitrophanous, K. A.
Palfi, S.
MOVEMENT DISORDERS, 2008, 23 (01) : S30 - S31
[5] ProSavin® a gene therapy approach for the treatment of Parkinson's Disease: a Phase I Clinical Trial Update
Palfi, Stephane
Watts, Collin
Marc, Gurruchaga Jean
Peter, Buttery
Scott, Ralph
Sarah, Deeley
Helene, Lepetit
James, Miskin
Hiro, Iwamuro
Sonia, Lavisse
Aurelie, Kas
Laure, Ramelli Anne
Naoki, Tani
Gilles, Fenelon
Pierre, Brugie're
Stuart, Naylor
Philippe, Hantraye
Philippe, Remy
Roger, Barker
Kyriacos, Mitrophanous
HUMAN GENE THERAPY, 2012, 23 (10) : A61 - A61
[6] ProSavin® a Gene Therapy Approach for the Treatment of Parkinson's Disease: Phase I Clinical Trial Update
Palfi, S.
Gurruchaga, J-M
Scorer, S.
Ralph, S.
Lepetit, H.
Jarraya, B.
Miskin, J.
Iwamuro, H.
Lavisse, S.
Ramelli, A. L.
Tani, N.
Dolphin, P.
Abhay, K.
Gabriel, I.
Fenelon, G.
Brugiere, P.
Kingsman, S.
Price, G.
Naylor, S.
Hantraye, P.
Remy, P.
Mitrophanous, K.
HUMAN GENE THERAPY, 2011, 22 (10) : A20 - A20
[7] Triple-gene therapy in Parkinson disease (ProSavin): Toward a putaminal dopamine factory?
Anheim, M.
REVUE NEUROLOGIQUE, 2014, 170 (02) : 89 - 90
[8] ProSavin® a Gene Therapy Approach for Parkinson Disease: Phase I Clinical Trial Update
Palfi, S.
Jarraya, B.
Gurruchaga, J-M
Ralph, S.
Lepetit, H.
Lavisse, S.
Miskin, J.
Kas, A.
Fenelon, S.
Brugiere, P.
Kingsman, S.
Naylor, S.
Hantraye, P.
Remy, K.
Mitrophanous, K.
HUMAN GENE THERAPY, 2010, 21 (10) : 1364 - 1364
[9] A phase I/II clinical trial to evaluate the safety and efficacy of ProSavin®, a gene therapy approach for Parkinson's disease
Jarraya, B.
Lepetit, H.
Ralph, S.
Boulet, S.
Jan, C.
Bonvento, G.
Miskin, J.
Gurruchaga, J. -M.
Vinti, M.
Fenelon, G.
Brugiere, P.
Kingsman, S.
Hantraye, P.
Remy, P.
Mitrophanous, K.
Palfi, S.
PARKINSONISM & RELATED DISORDERS, 2009, 15 : S145 - S145
[10] Prosavin®, a dopamine gene therapy for advanced Parkinson's disease: 5 years phase I/II clinical update
Palfi, S.
Gurruchaga, J. M.
Watts, C.
Buttery, P. C.
Lepetit, H.
Fenelon, G.
Binley, K.
Howard, K.
Lad, Y.
Tuckwell, N. J.
Hantraye, P.
Barker, R. A.
Mitrophanous, K. A.
HUMAN GENE THERAPY, 2018, 29 (12) : A87 - A87

← 1 2 3 4 5 →